Literature DB >> 8361767

Structural analysis of the human ret proto-oncogene using exon trapping.

J B Kwok1, E Gardner, J P Warner, B A Ponder, L M Mulligan.   

Abstract

A genomic contig of the human ret protooncogene was created with four overlapping cosmid clones isolated from two libraries. After southern analysis with portions of the ret cDNA, eight cosmid fragments were analysed in detail for the presence of ret exons using exon trapping. PCR products corresponding to spliced exons were isolated and subcloned. Exon boundaries were delineated by comparison of the PCR product sequence and the published ret cDNA sequence. The exons were initially positioned on a genomic map defined by BamHI, EcoRI and HindIII restriction sites. The positions of the exons were then refined by amplifying genomic DNA using primer pairs derived from one or more exons along the ret gene, the length of the PCR product indicating the approximate genomic distance between the exon sequences. The ret proto-oncogene is composed of at least 20 exons, ranging in size from 60 bp to 287 bp, distributed along 30 kb of genomic DNA. The extracellular domain is encoded by 10 exons and the cytoplasmic domain by 9 exons. The transmembrane domain is encoded by a single exon.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8361767

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  15 in total

1.  Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases.

Authors:  Syed A Ahmed; Karen Snow-Bailey; W Edward Highsmith; Weimin Sun; Raymond G Fenwick; Rong Mao
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

2.  Molecular heterogeneity of RET loss of function in Hirschsprung's disease.

Authors:  F Carlomagno; G De Vita; M T Berlingieri; V de Franciscis; R M Melillo; V Colantuoni; M H Kraus; P P Di Fiore; A Fusco; M Santoro
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 3.  The RET proto-oncogene: a challenge to our understanding of disease pathogenesis.

Authors:  T Kusafuka; P Puri
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

4.  Analysis of the RET, GDNF, EDN3, and EDNRB genes in patients with intestinal neuronal dysplasia and Hirschsprung disease.

Authors:  R Gath; A Goessling; K M Keller; S Koletzko; W Coerdt; H Müntefering; S Wirth; R M Hofstra; L Mulligan; C Eng; A von Deimling
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

5.  RET proto-oncogene mutations and rearrangements in endocrine diseases.

Authors:  R V Lloyd
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

6.  Molecular evolution of the genes encoding receptor tyrosine kinase with immunoglobulinlike domains.

Authors:  D Rousset; F Agnès; P Lachaume; C André; F Galibert
Journal:  J Mol Evol       Date:  1995-10       Impact factor: 2.395

7.  A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients.

Authors:  Wolfgang Gartner; Ivelina Mineva; Teodora Daneva; Sabina Baumgartner-Parzer; Bruno Niederle; Heinrich Vierhapper; Michael Weissel; Ludwig Wagner
Journal:  Hum Genet       Date:  2005-04-20       Impact factor: 4.132

8.  RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system.

Authors:  Felix Rückert; Heike Görgens; Ines Richter; Dietmar Krex; Gabriele Schackert; Eberhard Kuhlisch; Guido Fitze; Hans-Detlev Saeger; Christian Pilarsky; Robert Grützmann; Hans K Schackert
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

9.  Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing.

Authors:  P Komminoth; E Kunz; O Hiort; S Schröder; X Matias-Guiu; G Christiansen; J Roth; P U Heitz
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.

Authors:  P Edery; A Pelet; L M Mulligan; L Abel; T Attié; E Dow; D Bonneau; A David; W Flintoff; D Jan
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.